Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT03656705
Eligibility Criteria:
Inclusion Criteria:
* 1.Male and female subjects with non-small cell lung carcinoma in patients with no available curative treatment options who have limited prognosis(≧3 months)with currently available therapies will be enrolled.
* 2.The last cytotoxic drug, radiotherapy or surgery≧4 weeks.
* 3.HB≧90g/L, ANC≧1.5×10e9/L, PLT≧80×10e9/L, TBIL≦1.5×upper limit of nomal, ALT/AST≦2.5×upper limit of nomal, ALT/AST≦5×upper limit of nomal if have liver metastasis, Cr≦1.5×upper limit of nomal or CCr≧60ml/min.
Exclusion Criteria:
* 1.Pregnancy or breastfeeding.
* 2.Known HIV, HBV or HCV infection.
* 3.Active antoimmune disease.
* 4.History of severe immediate hypersensitivity to any of the biological products including penicillin.
* 5.Severe psychiatric disorder which might interfere with the study treatment or examination.
* 6.Chronic heart failure NYHA≧III.
* 7.Simultaneous participation in another clinical trial within 4 weeks.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03656705
Study Brief:
Protocol Section:
NCT03656705